Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**FOXK2 antisense RNA 1 (FOXK2-AS1)** is a predicted long noncoding natural antisense RNA transcribed from the opposite strand of the FOXK2 gene. While the existence of closely related antisense RNAs (e.g., Foxk1-AS in mouse) and similar lncRNA antisense transcripts (e.g., FOXC2-AS1) have been described and shown to post-transcriptionally regulate their sense gene by modulating mRNA stability or translation, there is currently no published experimental evidence describing the biological function, disease relevance, or therapeutic targeting of FOXK2-AS1 itself in humans[2][3][4]. Most literature and genomic databases reference FOXK2, a forkhead transcription factor, but not its antisense RNA[1][4]. The available data support FOXK2-AS1 as a natural antisense RNA with possible regulatory potential, but information specific to its function, disease association, or druggability is lacking, indicating this is not presently considered a defined therapeutic target. **Clarifications and limitations:** - FOXK2-AS1 appears to be an *inferred* entity by analogy to other forkhead gene antisense RNAs (such as Foxk1-AS and FOXC2-AS1)[2][3], but there is no experimental data or recognized authoritative source confirming this transcript for FOXK2 in human or mouse. - Therefore, listing it as a current therapeutic target is not supported, and most biomedical resources do not catalog FOXK2-AS1 as a validated or characterized molecule. - The nomenclature may reflect systematic cataloging of noncoding RNAs, but not all proposed antisense transcripts are experimentally supported or assigned clinical or molecular roles. **Summary:** FOXK2-AS1 is a hypothesized long noncoding antisense RNA to the FOXK2 gene, analogous to characterized NATs in related forkhead genes, but is not currently validated as a functional molecule or therapeutic target, and thus some information (e.g., biological function, interacting drugs) remains unknown or unsupported[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FOXK2 antisense RNA 1 (FOXK2-AS1).